{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T17:31:19Z","timestamp":1726421479750},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.medcli.2016.02.022","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T06:17:44Z","timestamp":1461651464000},"page":"561.e1-561.e8","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gesti\u00f3n cardiovascular de los pacientes con leucemia mieloide cr\u00f3nica desde una perspectiva multidisciplinar, y propuesta de protocolo de actuaci\u00f3n por reuni\u00f3n de consenso"],"prefix":"10.1016","volume":"146","author":[{"given":"Valent\u00edn","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Jim\u00e9nez-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Teresa","family":"G\u00f3mez-Casares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferm\u00edn","family":"S\u00e1nchez-Guijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"L\u00f3pez-Send\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Steegmann Olmedillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.02.022_bib0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.medcli.2016.02.022_bib0065","doi-asserted-by":"crossref","first-page":"e2014005","DOI":"10.4084\/mjhid.2014.005","article-title":"Treatment recommendations for chronic myeloid leukemia","volume":"6","author":"Baccarani","year":"2014","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"10.1016\/j.medcli.2016.02.022_bib0070","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe--Epidemiological update 2015","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2016.02.022_bib0075","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2016.02.022_bib0080","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: A roadmap to the next level","volume":"65","author":"Barac","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2016.02.022_bib0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/17474086.2015.1041910","article-title":"Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Update on key adverse events","volume":"8","author":"Carneiro","year":"2015","journal-title":"Expert Rev Hematol."},{"key":"10.1016\/j.medcli.2016.02.022_bib0090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.92.92","article-title":"ENESTnd update: Nilotinib vs imatinib in patients with newly diagnosed CML-CP and the impact of early molecular response and sokal risk at diagnosis on long-term outcomes","author":"Saglio","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2016.02.022_bib0095","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.152.152","article-title":"Final study results of the phase 3 dasatinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) trial (DASISION, CA180-056)","author":"Cort\u00e9s","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2016.02.022_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2014.868629","article-title":"2013 ESH\/ESC practice guidelines for the management of arterial hypertension","volume":"23","author":"Mancia","year":"2014","journal-title":"Blood Press"},{"key":"10.1016\/j.medcli.2016.02.022_bib0105","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2016.02.022_bib0110","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/leu.2014.342","article-title":"Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia","volume":"29","author":"Rea","year":"2015","journal-title":"Leukemia."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T02:57:38Z","timestamp":1600484258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775316001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0025775316001275"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.02.022","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gesti\u00f3n cardiovascular de los pacientes con leucemia mieloide cr\u00f3nica desde una perspectiva multidisciplinar, y propuesta de protocolo de actuaci\u00f3n por reuni\u00f3n de consenso","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}